China has approved CSPC Pharma’s RSV vaccine for clinical trials
China’s National Drug Administration has issued a release authorization to pharmaceutical group CSPC The drugmaker said it will begin clinical trials of a respiratory syncytial virus (RSV) vaccine in humans.
POPULAR POSTS
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVE STREAM